PREPL and cancer: Other genes, such as PREPL (prolyl endopeptidase-like—usually involved in neurological and metabolic pathways) and MTURN (a neural progenitor differentiation regulator associated with cancer progression), emerged as potential biomarkers influencing survival outcomes.